Gladell P. Paner to Prostatic Neoplasms, Castration-Resistant
This is a "connection" page, showing publications Gladell P. Paner has written about Prostatic Neoplasms, Castration-Resistant.
Connection Strength
0.194
-
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
Score: 0.119
-
SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene. 2022 Feb; 41(8):1190-1202.
Score: 0.044
-
Circulating tumor cells capture disease evolution in advanced prostate cancer. J Transl Med. 2017 02 23; 15(1):44.
Score: 0.031